arstechnica.com

To keep drug prices high, pharma has been piling up the patents - Ars Technica

Add-on patents have increased drug patent periods from two years to over six.

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.